EncounterCare Solutions, Inc.

EncounterCare Solutions, Inc. operates as an energy and healthcare company in the United States. It operates through Energy and Healthcare Services divisions. The Energy division produces and distributes a fuel additive under the EcoFlex 96 and Dynamo brand names. The Healthcare Services division offers a suite of pediatric and neonatal services, including skilled nursing, home infusion, medical equipment, and others. The company was formerly known as Ecare Solutions, Inc. and changed its name to EncounterCare Solutions, Inc. in November 2000. EncounterCare Solutions, Inc. is headquartered in Palm Beach Gardens, Florida.

EncounterCare Solutions, Inc. trades as ECSL on OTC. The company is classified in Industrials / Conglomerates and reports in USD.

The current profile places the business in Conglomerates. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $423,731 of revenue and -$1.95M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

EncounterCare Solutions, Inc. can be compared against peers such as Coventry Group Ltd, Gol Linhas Aéreas Inteligentes S.A., Midwest Energy Emissions Corp., Megola, Inc., Noble Group Limited, PPK Group Limited.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $66.82M, beta of 0.52, and return on equity of +302.4%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

ECSL currently shows total debt of $1.54M and beta of 0.52. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.encountercare.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.